Lethal capillary leak syndrome after a single administration of interferon beta-1b

Neurology

Volumn 53, Issue 1, 1999, Pages 220-222

  Schmidt, S ^b   Hertfelder, H J ^b   Von Spiegel, T ^b   Hering, R ^b   Harzheim, M ^b   Lassmann, H ^b   Deckert Schluter M ^b   Schlegel, Uwe ^a  

^a UNIVERSITY OF BONN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; INTERFERON BETA SERINE; METHYLPREDNISOLONE; PARACETAMOL;

ADULT; ARTICLE; AUTOPSY; CAPILLARY LEAK SYNDROME; CASE REPORT; COMPLEMENT DEFICIENCY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; LETHALITY; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; WHITE MATTER;

EID: 0033551450     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.1.220     Document Type: Article

References (10)

1. The IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993;43:655-661.
2. Arnason BG, Dayal A, Qu ZW, Jensen MA, Genc K, Reder AT. Mechanism of action of interferon-β in multiple sclerosis. Springer Semin Immunopathol 1996;18:125-148.
3. Thijs LG, Hack CE, Strack van Schijndel RJM, et al. Activation of the complement system during immunotherapy with interleukin-2: relation to the development of side effects. J Immunol 1990;144:2419-2424.
4. Holler E, Kolb HJ, Moller A, et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990;75:1011-1016.
5. Davis AE. C1-inhibitor and hereditary angioneurotic edema. Annu Rev Immunol 1988;6:595-628.
6. He S, Tsang S, North J, Chohan N, Sim RB, Whaley K. Epitope mapping of C1 inhibitor autoantibodies from patients with acquired C1 inhibitor deficiency. J Immunol 1996;156: 2009-2013.
7. Eisele B, Delvos U. From angioedema to generalized capillary leak syndrome: evidence for a pivotal role of C1-inhibitor in septic shock-like syndromes. In: Reinhardt K, Eyrich K, Sprung C, eds. Sepsis: current perspectives in pathophysiology and therapy. Berlin: Springer, 1994:501-527.
8. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
9. Trefouret S, Azulay JP, Pouget J, Boucraut J, Serratrice G. Late-onset multiple sclerosis and serum monoclonal gammopathy: an incidental association? Rev Neurol (Paris) 1996; 152:554-569.
10. Hiraoka E, Matsushima Y, Inomoto-Naribayashi Y, et al. Systemic capillary leak syndrome associated with multiple myeloma of IgG kappa type. Intern Med 1995;34:1220-1224.